Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses

Roel Vermeulen, Fatemeh Saberi Hosnijeh, Barbara Bodinier, Lutzen Portengen, Benoit Liquet, Javiera Garrido-Manriquez, Henk Lokhorst, Ingvar A. Bergdahl, Soterios A. Kyrtopoulos, Ann-Sofie Johansson, Panagiotis Georgiadis, Beatrice Melin, Domenico Palli, Vittorio Krogh, Salvatore Panico, Carlotta Sacerdote, Rosario Tumino, Paolo Vineis, Raphaele Castagne, Marc Chadeau-HyamMaria Botsivali, Aristotelis Chatziioannou, Ioannis Valavanis, Jos C. S. Kleinjans, Theo M. C. M. de Kok, Hector C. Keun, Toby J. Athersuch, Rachel Kelly, Per Lenner, Goran Hallmans, Euripides G. Stephanou, Antonis Myridakis, Manolis Kogevinas, Lucia Fazzo, Marco De Santis, Pietro Comba, Benedetta Bendinelli, Hannu Kiviranta, Panu Rantakokko, Riikka Airaksinen, Paivi Ruokojarvi, Mark Gilthorpe, Sarah Fleming, Thomas Fleming, Yu-Kang Tu, Thomas Lundh, Kuo-Liong Chien, Wei J. Chen, Wen-Chung Lee, Chuhsing Kate Hsiao, EnviroGenomarkers Consortium

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1335-1347
Number of pages13
JournalInternational Journal of Cancer
Volume143
Issue number6
DOIs
Publication statusPublished - 15 Sep 2018

Keywords

  • lymphoma
  • multiple myeloma
  • cytokine
  • prospective cohort
  • mixed-effect modeling
  • multivariate models
  • time to diagnosis
  • NON-HODGKIN-LYMPHOMA
  • TRANSFORMING-GROWTH-FACTOR
  • SERUM-LEVELS
  • FACTOR-ALPHA
  • BONE-MARROW
  • INDEPENDENT PREDICTOR
  • CYTOKINE LEVELS
  • POOR-PROGNOSIS
  • OVARIAN-CANCER
  • SOLUBLE CD30

Cite this